The increased production of neutrophil chemoattractants such as IL-8, Stx-mediated ERK1/2 activation promotes inflammation and the systemic uptake of Stx, leading to the onset of HUS [114]. Here, MAPK3 is linked to hemolytic-uremic syndrome.